Within the next six months, clinical trials of his company’s Neuralink chip in humans will begin. Elon Musk which is implanted in the brain.

As Musk himself stated, this chip can restore vision, mobility and communication to people who have such problems.

Founded and owned by (but not by the CEO of) the world’s richest man, Neuralink is a medical technology company founded in 2016 and headquartered in San Francisco, California and Austin, Texas.

So far, the company has only tested on animals, but is now seeking permission from the US Food and Drug Administration (FDA) to test its technology on humans.

“We want to be absolutely careful and make sure it works well before we put the device inside a person,” Musk said, expressing optimism that in about six months the FDA will give its approval and human trials can begin. .

“Even if someone has never had sight because they were born blind, we believe that we can restore their sight,” he said in a live broadcast of the Neuralink event, which was broadcast live.

Great plans

Neuralink’s last announcement came over a year ago when it publicly unveiled a brain-chip monkey that controlled a computer with its mind alone.

Since he has stated that he intends to colonize Mars and save humanity, Musk’s goals and ambitions for Neuralink are also extremely high.

The key goal of Elon Musk’s company is to develop an electronic brain implant that, if tuned correctly every time, will allow various medical “miracles” to be performed, such as making the blind see, paralyzed to walk, and cure people with dementia, Alzheimer’s and other diseases. Parkinson’s disease. At some point, it also provides for the “marriage” of the human brain with artificial intelligence.

he stayed behind

At the moment – and more realistically – Neuralink is showing slow progress. Human trials have already been announced since 2019, but Musk’s company consistently missed the required deadline to apply for FDA approval.

Rival Synchron appears to be leading the way, having already implanted the chip on a US patient for the first time in July, and has also tested it on four people in Australia.

Musk himself admitted at yesterday’s presentation that the Neuralink chip development process may seem “painfully slow,” but every effort is being made to achieve the end goal.

According to Reuters